PwC Pharma & Life Sciences Webinar: COVID-19 impact on the ITX and regulatory DNA

Dear pharma & life sciences colleagues,

It was a pleasure to welcome you to our webinar: PwC Pharma & Life Sciences Webinar: COVID-19 impact on the ITX and regulatory DNA.

Attached below you can download the presentation.

Continue reading PwC Pharma & Life Sciences Webinar: COVID-19 impact on the ITX and regulatory DNA

How healthy is your value chain?

Do you know how healthy the value chain of your company is? Let’s have a look at some key questions in the pre- and post-marketing authorization life cycle of pharmaceuticals:

How healthy is your value chain

My recommendation on your next steps:

Choose a holistic approach in order to assess and possibly optimise the health of your value chain (tax, legal, regulatory, operational, digital etc.).
Use “scientific” out of the box thinking, innovation and an efficient delivery model as the tools to success.

Happy to discuss.
Have a nice summer day.

Sandra